Evaluation of retinal function and flicker light-induced retinal vascular response in normotensive patients with diabetes without retinopathy

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 6, 2011, Pages 2861-2867

  Lecleire Collet, Amélie ^a   Audo, Isabelle ^b   Aout, Mounir ^a   Girmens, Jean François ^b   Sofroni, Rénata ^a   Erginay, Ali ^a   le Gargasson, Jean François ^b   Mohand Saïd, Saddek ^b   Meas, Taly ^c   Guillausseau, Pierre Jean ^c   Vicaut, Eric ^a   Paques, Michel ^b   Massin, Pascale ^a,b  

^a HÔPITAL FERNAND WIDAL   (France)

^b INSERM   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ALPHA RHYTHM; ANALYZER; ARTICLE; BETA RHYTHM; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; COLOR VISION; CONTRAST SENSITIVITY; CONTROLLED STUDY; CRITICAL FLICKER FUSION; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NIGHT VISION; NON INSULIN DEPENDENT DIABETES MELLITUS; OSCILLATORY POTENTIAL; PHOTOPIC VISION; PHOTOSTIMULATION; PRIORITY JOURNAL; RESPONSE TIME; RETINA BLOOD VESSEL; RETINA NERVE CELL; SEX DIFFERENCE; VISUAL SYSTEM FUNCTION;

ADULT; COLOR PERCEPTION; CONTRAST SENSITIVITY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; FEMALE; HUMANS; LIGHT; MALE; MIDDLE AGED; PHOTIC STIMULATION; RETINA; RETINAL VESSELS; YOUNG ADULT;

EID: 79955969923     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5960     Document Type: Article

References (36)

1. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:283-290.
2. Antonetti DA, Barber AJ, Bronson SK, et al. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes. 2006;55:2401-2411.
3. Garhofer G, Zawinka C, Resch H, Kothy P, Schmetterer L, Dorner GT. Reduced response of retinal vessel diameters to flicker stimulation in patients with diabetes. Br J Ophthalmol. 2004;88:887-891.
4. Mandecka A, Dawczynski J, Blum M, et al. Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care. 2007;30:3048-3052.
5. Bek T, Hajari J, Jeppesen P. Interaction between flicker-induced vasodilatation and pressure autoregulation in early retinopathy of type 2 diabetes. Graefes Arch Clin Exp Ophthalmol. 2008;246: 763-769.
6. Nguyen TT, Kawasaki R, Wang JJ, et al. Flicker-light induced retinal vasodilation in diabetes and diabetic retinopathy. Diabetes Care. 2009;32:2075-2080.
7. Mandecka A, Dawczynski J, Vilser W, et al. Abnormal retinal autoregulation is detected by provoked stimulation with flicker light in well-controlled patients with type 1 diabetes without retinopathy. Diabetes Res Clin Pract. 2009;86:51-55.
8. Pemp B, Garhofer G, Weigert G, et al. Reduced retinal vessel response to flicker stimulation but not to exogenous nitric oxide in type 1 diabetes. Invest Ophthalmol Vis Sci. 2009;50:4029-4032.
9. Pemp B, Weigert G, Karl K, et al. Correlation of flicker-induced and flow-mediated vasodilatation in patients with endothelial dysfunction and healthy volunteers. Diabetes Care. 2009;32:1536-1541.
10. Nagel E, Vilser W, Lanzl I. Age, blood pressure, and vessel diameter as factors influencing the arterial retinal flicker response. Invest Ophthalmol Vis Sci. 2004;45:1486-1492.
11. Bowman KJ. A method for quantitative scoring of the Farnsworth Panel D-15. Acta Ophthalmol. 1982;60:907-916.
12. Holder GE, Brigell MG, Hawlina M, Meigen T, Vaegan, Bach M. ISCEV standard for clinical pattern electroretinography: 2007 update. Doc Ophthalmol. 2007;114:111-116.
13. Marmor MF, Holder GE, Seeliger MW, Yamamoto S. Standard for clinical electroretinography (2004 update). Doc Ophthalmol. 2004;108:107-114.
14. Hood DC, Bach M, Brigell M, et al. ISCEV guidelines for clinical multifocal electroretinography (2007 edition). Doc Ophthalmol. 2008;116:1-11.
15. Yonemura D. [An electrophysiological study on activities of neuronal and non-neuronal retinal elements in man with reference to its clinical application]. Nippon Ganka Gakkai Zasshi. 1977;81: 1632-1665.
16. Yoshida A, Kojima M, Ogasawara H, Ishiko S. Oscillatory potentials and permeability of the blood-retinal barrier in noninsulin-dependent diabetic patients without retinopathy. Ophthalmology. 1991; 98:1266-1271.
17. Vilser W, Nagel E, Lanzl I. Retinal vessel analysis, new possibilities. Biomed Tech (Berl.) 2002;47:682-685.
18. Nagel E, Vilser W, Fink A, Riemer T. [Variance of retinal vessel diameter response to flicker light: a methodical clinical study]. Ophthalmologe. 2006;103:114-119.
19. Nguyen T, Kawasaki R, Kreis AJ, et al. Correlation of light-flickerinduced retinal vasodilation and retinal vascular caliber measurements in diabetes. Invest Ophthalmol Vis Sci. 2009;50:5609-5613.
20. Dorner GT, Garhöfer G, Huemer KH, Riva CE, Wolzt M, Schmetterer L. Hyperglycemia affects flicker-induced vasodilation in the retina of healthy subjects. Vision Res. 2003;43:1495-1500.
21. Formaz F, Riva CE, Geiser M. Diffuse luminance flicker increases retinal vessel diameter in humans. Curr Eye Res. 1997;16:1252- 1257.
22. Buerk DG, Riva CE, Cranstoun SD. Nitric oxide has a vasodilatory role in cat optic nerve head during flicker stimuli. Microvasc Res. 1996;52:13-26.
23. Dorner GT, Garhofer G, Kiss B, et al. Nitric oxide regulates retinal vascular tone in humans. Am J Physiol Heart Circ Physiol. 2003; 285:631-636.
24. Riva CE, Logean E, Falsini B. Visually evoked hemodynamical response and assessment of neurovascular coupling in the optic nerve and retina. Prog Retin Eye Res. 2005;24:183-215.
25. Kern TS, Barber AJ. Retinal ganglion cells in diabetes. J Physiol. 2008;586:4401-4408.
26. Luu CD, Szental JA, Lee SY, Lavanya R, Wong TY. Correlation between retinal oscillatory potentials and retinal vascular caliber in type 2 diabetes. Invest Ophthalmol Vis Sci. 2010;51:482-486.
27. Hardy KJ, Fisher C, Heath P, Foster DH, Scarpello JH. Comparison of colour discrimination and electroretinography in evaluation of visual pathway dysfunction in aretinopathic IDDM patients. Br J Ophthalmol. 1995;79:35-37.
28. Kurtenbach A, Schiefer U, Neu A, Zrenner E. Preretinopic changes in the colour vision of juvenile diabetics. Br J Ophthalmol. 1999; 83:43-46.
29. Greenstein VC, Shapiro A, Zaidi Q, Hood DC. Psychophysical evidence for post-receptoral sensitivity loss in diabetics. Invest Ophthalmol Vis Sci. 1992;33:2781-2790.
30. Holopigian K, Seiple W, Lorenzo M, Carr R. A comparison of photopic and scotopic electroretinographic changes in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 1992;33:2773-2780.
31. Juen S, Kieselbach GF. Electrophysiological changes in juvenile diabetics without retinopathy. Arch Ophthalmol. 1990;108:372-375.
32. Coupland SG. A comparison of oscillatory potential and pattern electroretinogram measures in diabetic retinopathy. Doc Ophthalmol. 1987;66:207-218.
33. Wachtmeister L. Oscillatory potentials in the retina: what do they reveal. Prog Retin Eye Res. 1998;17:485-521.
34. Holder GE. Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis. Prog Retin Eye Res. 2001; 20:531-561.
35. Stewart WC, Chauhan BC. Newer visual function tests in the evaluation of glaucoma. Surv Ophthalmol. 1995;40:119-135.
36. Riva CE, Salgarello T, Logean E, Colotto A, Galan EM, Falsini B. Flicker-evoked response measured at the optic disc rim is reduced in ocular hypertension and early glaucoma. Invest Ophthalmol Vis Sci. 2004;45:3662-3668.